Comparative Evaluation of the Results of Facet Joint Injections

Not Applicable

Completed

• Conditions: Low Back Pain, Mechanical; Facet Syndrome of Lumbar Spine
• Interventions: Procedure: Intra-articular injection to lumbar facet joint

• Registration Number: NCT06325631
• Lead Sponsor: Oznur Uzun

Brief Summary

Low back pain affects 60 to 90% of the total population. It is one of the most common causes of disability in adults. Low back pain can be originated from a wide variety of structures, and the facet joint is one of these structures. It is thought that 21 to 41% of low back pain originates from the facet joint. A wide variety of conservative treatments, including intra-articular injections, are used to treat low back pain originating from the facet joint. However, there is still no consensus on the most effective treatment method. With appropriate patient selection, facet joint injections can provide significant improvements in patients' pain scores. After Goldthwait defined the facet joint concept in 1911, Ghormley defined facet joint syndrome in 1933. The source of pain in 40-50% of patients is the lumbar facet joints. Innervation of the lumbar facet joints is provided by the medial branches of the dorsal roots of the spinal nerves. In 1975, Shealy described the coagulation of the articular nerve support of the spinal facet joints with the radiofrequency method. These methods have been further developed over time. The results of facet joint injections are satisfactory in well-selected patient groups. It has been shown that intra-articular steroid injection to the facet joint is superior to systemic steroid use in patients with low back pain. In this study, it was aimed to methodically compare the facet joint injections applied to patients diagnosed with facet syndrome in the outpatient clinic of the Physical Therapy and Rehabilitation Hospital in terms of patient pain scores, application time, effort spent and patient anxiety. Intra-articular injections will be performed under by fluoroscopy or ultrasound guidance or anatomic location.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-02
• Study First Submitted: 2024-03-10
• Study First Submitted QC: 2024-03-16
• Study First Posted: 2024-03-22
• Primary Completion: 2024-03-31
• Study Completion: 2024-04-30
• Status Verified: 2024-08
• Last Update Submitted: 2024-08-20
• Last Update Posted: 2024-08-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Patients with facet joint syndrome diagnosis

Exclusion Criteria

• pregnant patients
• breastfeeding patients
• patients with cardiac pacemaker

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Anatomic	Intra-articular injection to lumbar facet joint	-
Fluoroscopy	Intra-articular injection to lumbar facet joint	-
Ultrasound	Intra-articular injection to lumbar facet joint	-

Primary Outcome Measures

Name	Time	Method
Visual Analogue Scale	VAS will be applied to the patients before the procedure and at the first and twelfth week after the procedure	Pain intensity will be measured with Visual Analogue Scale, which is used to measure musculoskeletal pain with very good reliability and validity. Visual Analogue Scale is between 0-10 cm. 0 means no pain, 10 means the most severe pain.

Trial Locations

Locations (1)

Ankara Bilkent Şehir Hastanesi; 🇹🇷 Ankara, Turkey